Clinical Trial Results for Polymyalgia Rheumatica (PMR)
1 Clinical Trials for Polymyalgia Rheumatica (PMR)
RECRUITING
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
Description
The purpose of this extension study is to assess the safety and tolerability of secukinumab when administered long-term in patients with polymyalgia rheumatica.